Cytek BioSciences IncCTKB
Price$5.81Intrinsic value$6.8919% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $6.89median of 2 methodsbased on filings through 30 Jun 2026
Market Price $5.81Price as of 1 Oct 2026
Margin of Safety +18.7%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 31.2%/yr (balance of the path).25.5% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 629.0%Yr 726.7%Yr 824.5%Yr 922.2%Yr 1020.0%
31.2% → 20.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1118.3%Yr 1216.6%Yr 1314.9%Yr 1413.2%Yr 1511.5%Yr 169.8%Yr 178.1%Yr 186.4%Yr 194.7%Yr 203.0%
20.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 9.9%
Volatility vs market (adjusted beta)1.10

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetCytek BioSciences IncCTKBHealth Care
Valuation
P/E—
P/S3.3×
P/B2.1×
EV / Revenue3.0×
EV / EBITDA-7.5×
Profitability
Gross margin51.8%
Operating margin-20.1%
Net margin-39.0%
FCF margin-5.8%
Returns
ROE-25.0%
ROA-18.0%
ROIC—
Growth
Revenue growth (YoY)3.1%
5-yr fwd EPS growth25.5%
Financial strength
Debt / Equity0.00×
Current ratio4.48×
Altman Z-Score4.1
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.